Office of the Director, National Institutes of Health; Notice of Meeting, 50051-50052 [2019-20596]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 185 / Tuesday, September 24, 2019 / Notices
and $68.8 billion in total societal costs.1
In contrast, adult vaccination coverage
rates have remained persistently low,
with only modest gains for certain
populations in the past few years.2 As
a result, the standards for adult
immunization practice were updated in
2014 to promote integration of vaccines
into routine clinical care for adults.3
Despite the widespread availability of
effective vaccines, vaccine-preventable
diseases (VPDs) remain a significant
public health challenge. In particular,
rates of non-medical exemptions for
childhood vaccines are increasing,4 and
there have been recent measles
outbreaks in the U.S.5 and globally, due
to growing vaccine hesitancy and
coverage levels below the threshold
needed for herd immunity. With an
estimated cost of $20,000 per case of
measles to the public sector in 2016,6
the economic consequences of this and
other VPDs, as well as the health
consequences, are significant.
Furthermore, few adults in any age
group are fully vaccinated as
recommended by the Advisory
Committee on Immunization Practices.
Large disparities in vaccine coverage by
race/ethnicity persist, with African
Americans, Hispanics, and Asian
Americans lagging behind whites in
nearly all vaccination coverage rates.7
VPDs such as pertussis and hepatitis B
continue to take a heavy toll on public
health,8 with 18,975 cases of pertussis
and 3,409 (22,000 estimated) cases of
hepatitis B infections reported in the
United States in 2017.9 10 In light of
khammond on DSKJM1Z7X2PROD with NOTICES
1 Zhou
F et al. Economic evaluation of the routine
childhood immunization program in the United
States, 2009. Pediatrics. 2014; 133: 1–9.
2 https://www.cdc.gov/vaccines/imz-managers/
coverage/adultvaxview/pubs-resources/NHIS2017.html.
3 National Vaccine Advisory Committee.
Recommendations from the National Vaccine
Advisory Committee: standards for adult
immunization practice. Public Health Rep.
2014;129:115–23.
4 Omer, S. et al. Nonmedical exemptions to
school immunization requirements: secular trends
and association of state policies with pertussis
incidence. JAMA. 2006;296(14):1757–1763.
5 https://www.cdc.gov/measles/casesoutbreaks.html.
6 Lo NC, Hotez PJ. Public Health and Economic
Consequences of Vaccine Hesitancy for Measles in
the United States. JAMA Pediatr. 2017;171(9):887–
892. doi:10.1001/jamapediatrics.2017.1695.
7 Lu PJ et al. Racial and Ethnic Disparities in
Vaccination Coverage Among Adult Populations in
the U.S. Am J Prev Med. 2015;49(6 Suppl 4):S412–
S425. doi:10.1016/j.amepre.2015.03.005.
8 https://www.cdc.gov/vaccines/pubs/pinkbook/
downloads/appendices/e/reported-cases.pdf.
9 https://www.chop.edu/centers-programs/
vaccine-education-center/global-immunization/
diseases-and-vaccines-world-view.
10 Schillie et al. Prevention of Hepatitis B Virus
Infection in the United States: Recommendations of
the Advisory Committee on Immunization
Practices. MMWR. 2018;67(1):1–31.
VerDate Sep<11>2014
18:34 Sep 23, 2019
Jkt 247001
these challenges, strengthening the
vaccine and immunization enterprise is
a priority for HHS.
The 2010 National Vaccine Plan
(https://www.hhs.gov/sites/default/files/
nvpo/vacc_plan/2010-Plan/
nationalvaccineplan.pdf) and the
associated implementation plan (https://
www.hhs.gov/sites/default/files/nvpo/
vacc_plan/2010-2015-Plan/
implementationplan.pdf) have played
an important role in guiding strategies
and allocations of resources with
respect to vaccines and vaccination.
However, since the publication of the
2010 National Vaccine Plan, there have
been many changes in the vaccine
landscape.
To respond to the public health
challenges of VPDs, OIDP in
collaboration with other federal partners
is leading the development of the 2020
National Vaccine Plan. This updated
plan will recommend vaccine strategies
across the lifespan and guide priority
actions for the period 2020–2025. To
develop this plan, HHS, through OIDP,
seeks input from subject matter experts
and nonfederal partners and
stakeholders such as health care
providers, national professional
organizations, health departments,
school administrators, communitybased and faith-based organizations,
manufacturers, researchers, advocates,
and persons affected by VPDs.
This request for information seeks
public input on strengthening and
improving the nation’s response to
VPDs and strategies to address
infectious diseases through vaccination.
The 2020 National Vaccine Program
requests information in five broad areas.
Responders may address one or more of
the areas below:
1. Priorities for the 2020 National
Vaccine Plan during 2020–2025. What
do you recommend as the top priorities
for vaccines and immunizations in the
United States? Why are these priorities
most important to you? [Provide up to
2 pages to answer these questions]
2. What changes should be made to
the 2010 National Vaccine Plan to make
it more current and useful? This could
include changes to the goals, objectives,
strategies, activities, indicators, and
other areas of the plan. Which
components of the 2010 National
Vaccine Plan worked well and should
be maintained? [Provide up to 2 pages
to answer these questions]
3. What are the goals, objectives, and
strategies for each of your top priority
areas? Are there any goals in the current
strategy that should be discarded or
revised? Which ones and why? [Provide
up to 2 pages to answer these questions]
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
50051
4. What indicators can be used to
measure your top priorities and goals?
Are there any indicators in the 2010
National Vaccine Plan or the National
Adult Immunization Plan (https://
www.hhs.gov/sites/default/files/nvpo/
national-adult-immunization-plan/
naip.pdf) that should continue to be
used? If so, which ones, and why?
[Provide up to 2 pages to answer these
questions]
5. Identify which stakeholders you
believe should have responsibility for
enacting the objectives and strategies
listed in the 2020 National Vaccine
Plan, as well as for any new objectives
and strategies you suggest. Specifically
identify roles that you or your
organization might have in the 2020
National Vaccine Plan. [Provide up to 2
pages to answer these questions].
The information received will inform
the development of the 2020 National
Vaccine Plan.
Dated: September 9, 2019.
Tammy R. Beckham,
Director, Office of Infectious Disease and HIV/
AIDS Policy.
[FR Doc. 2019–20415 Filed 9–23–19; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: NIH Clinical
Center Research Hospital Board.
Date: October 18, 2019.
Time: 9:00 a.m. to 2:40 p.m.
Agenda: Discussion of Patient Safety,
Quality Improvement Assessment, and
Medical Research Scholars Program.
Place: National Institutes of Health,
Building 1, Wilson Hall, One Center
Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, Office of the Director,
National Institutes of Health, One
Center Drive, Building 1, Bethesda, MD
20892, 301–496–4272, woodgs@nih.gov.
E:\FR\FM\24SEN1.SGM
24SEN1
50052
Federal Register / Vol. 84, No. 185 / Tuesday, September 24, 2019 / Notices
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 18, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20596 Filed 9–23–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; VSL
Fellowship Review.
VerDate Sep<11>2014
17:37 Sep 23, 2019
Jkt 247001
Date: October 16, 2019.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
6001 Executive Blvd., Room 8351, Bethesda,
MD 20892, 301–496–8683, singhs@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Hearing
and Balance Fellowship Review.
Date: October 18, 2019.
Time: 8:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
301–496–8683, el6r@nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Cooperative Agreement for Clinical Trials in
Communication Disorders (U01).
Date: October 29, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
301–496–8683, el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: September 17, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20594 Filed 9–23–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel R21–33
Application Review.
Date: October 2, 2019.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
6001 Executive Blvd., Room 8351, Bethesda,
MD 20892, 301–496–8683, singhs@
nidcd.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel NIDCD
Institutional Training Grant Review.
Date: October 3, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351, Bethesda, MD
20892, 301–496–8683 katherine.shim@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel
Chemosensory Fellowship Application
Review.
Date: October 10, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 84, Number 185 (Tuesday, September 24, 2019)]
[Notices]
[Pages 50051-50052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20596]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: October 18, 2019.
Time: 9:00 a.m. to 2:40 p.m.
Agenda: Discussion of Patient Safety, Quality Improvement
Assessment, and Medical Research Scholars Program.
Place: National Institutes of Health, Building 1, Wilson Hall, One
Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, Office of the
Director, National Institutes of Health, One Center Drive, Building 1,
Bethesda, MD 20892, 301-496-4272, [email protected].
[[Page 50052]]
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: September 18, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-20596 Filed 9-23-19; 8:45 am]
BILLING CODE 4140-01-P
